AmeriFlex Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

AmeriFlex Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.8K	Hold	205	–	–	0.02%	500
2026 Q1	$41.2K	Sell	205 -1	-0.5%	-$207	0.02%	460
2025 Q4	$42.5K	Sell	206 -174	-46%	-$34.8K	0.02%	445
2025 Q3	$68.1K	Buy	380 +216	+132%	+$36.8K	0.03%	408
2025 Q2	$26.5K	Sell	164 -110	-40%	-$17.5K	0.01%	513
2025 Q1	$46.6K	Sell	274 -14	-5%	-$2.43K	0.02%	483
2024 Q4	$52.1K	Buy	+288	New	+$49.2K	0.02%	430

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

AmeriFlex Group's FBT Position: Q2 2026 in Review

AmeriFlex Group held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 205 shares worth $50.8K. The position accounts for 0.02% of the portfolio, ranked #500.

AmeriFlex Group first reported a position in FBT in Q4 2024 and has held it in 7 quarters since. The position peaked at $68.1K in Q3 2025. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

AmeriFlex Group held 205 shares of First Trust NYSE Arca Biotechnology Index Fund worth $50.8K as of Q2 2026.
AmeriFlex Group left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of AmeriFlex Group's portfolio in Q2 2026, its #500 holding.
AmeriFlex Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2024 and has held it in 7 quarters since.
AmeriFlex Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $68.1K in Q3 2025.
339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.